<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25810" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neuromuscular Blockade</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cook</surname>
            <given-names>Danielle</given-names>
          </name>
          <aff>UPMC Pinnacle</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Simons</surname>
            <given-names>David J.</given-names>
          </name>
          <aff>UPMC Lititz</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Danielle Cook declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>David Simons declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25810.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Neuromuscular blockade is frequently used in anesthesia to facilitate endotracheal intubation, optimize surgical conditions, and assist with mechanical ventilation in patients with reduced lung compliance. Neuromuscular blocking agents (NMBAs) come in two forms: depolarizing neuromuscular blocking agents (eg, succinylcholine) and nondepolarizing neuromuscular blocking agents (eg, rocuronium, vecuronium, atracurium, cisatracurium, mivacurium). The class of NMBAs used for achieving neuromuscular blockade must be selected carefully based on patient factors, the type of procedure being performed, and clinical indication.</p>
        <p><bold>Depolarizing neuromuscular blockers:&#x000a0;</bold>Succinylcholine is the depolarizing neuromuscular blocker of choice. It is widely used due to its rapid onset and short duration of action, making it ideal for rapid sequence induction. Its mechanism of action involves binding to postsynaptic cholinergic receptors on the motor endplate, which causes rapid depolarization, fasciculation, and flaccid paralysis. <xref ref-type="bibr" rid="article-25810.r1">[1]</xref>&#x000a0;Usually, paralysis takes approximately 1 minute after administration and lasts approximately 7 to 12 minutes.<xref ref-type="bibr" rid="article-25810.r2">[2]</xref>&#x000a0;Succinylcholine is metabolized by plasma pseudocholinesterase. If the patient has pseudocholinesterase deficiency, this can lead to prolonged neuromuscular blockade that may require postoperative mechanical ventilation.<xref ref-type="bibr" rid="article-25810.r3">[3]</xref></p>
        <p><bold>Nondepolarizing neuromuscular blockers:&#x000a0;</bold>Nondepolarizing neuromuscular blockers can be classified into two classes based on their chemical structure: steroidal (eg, rocuronium, vecuronium, pancuronium) or benzylisoquinoline (eg, mivacurium, atracurium, cisatracurium). Nondepolarizing neuromuscular blockers are competitive acetylcholine (ACh) antagonists that bind directly to nicotinic receptors on the postsynaptic membrane, thus blocking the binding of ACh so the motor endplate cannot depolarize.<xref ref-type="bibr" rid="article-25810.r4">[4]</xref>&#x000a0;This leads to muscle paralysis.</p>
        <p><bold>Monitoring neuromuscular blockade:&#x000a0;</bold>Train-of-four (TOF) stimulation is the most common method utilized to monitor the extent of neuromuscular blockade. It consists of four consecutive 2 Hz stimuli to a chosen muscle group, and the respective number of twitches evoked, also known as train-of-four count (TOFC), provides information on the patient&#x02019;s recovery from neuromuscular blockade.</p>
        <list list-type="bullet">
          <list-item>
            <p>TOFC of 1 = &#x0003e;95% of receptors blocked</p>
          </list-item>
          <list-item>
            <p>TOFC of 2 = 85 to 90% of receptors blocked</p>
          </list-item>
          <list-item>
            <p>TOFC of 3 = 80 to 85% of receptors blocked</p>
          </list-item>
          <list-item>
            <p>TOFC of 4 = 70 to 75% of receptors blocked<xref ref-type="bibr" rid="article-25810.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>The train-of-four ratio (TOFR) is determined by dividing the amplitude of the fourth twitch by the amplitude of the first twitch. If the TOFR is &#x0003c;0.9, this indicates residual neuromuscular blockade and necessitates the use of a reversal agent. Reversal of neuromuscular blockade is commonly achieved with neostigmine, an anticholinesterase, and glycopyrrolate. However, sugammadex can also be used as a reversal agent if a steroidal NMBA is used.<xref ref-type="bibr" rid="article-25810.r6">[6]</xref></p>
      </sec>
      <sec id="article-25810.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>&#x000a0;<bold>Depolarizing NMBAs (eg, succinylcholine)</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>Neuromuscular Disorders: Succinylcholine causes transient hyperkalemia. In conditions associated with denervation and increased extrajunctional nicotinic acetylcholine receptors (nAChRs), like spinal cord injury and burn patients, administration may be life-threatening. Myasthenia gravis patients&#x000a0;are resistant to succinylcholine.</p>
          </list-item>
          <list-item>
            <p>Obesity: The dose of succinylcholine in obese patients should be based on total body weight to achieve optimal intubating conditions.</p>
          </list-item>
          <list-item>
            <p>Kidney Diseases: Succinylcholine remains an option for patients with renal disease, provided their potassium levels are within the normal range.</p>
          </list-item>
          <list-item>
            <p>Malignant hyperthermia: Avoid succinylcholine in patients with diagnosed malignant hyperthermia or a family history of malignant hyperthermia.<xref ref-type="bibr" rid="article-25810.r7">[7]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Nondepolarizing NMBAs</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Neuromuscular Disorders: Sensitivity to nondepolarizing NMBAs can vary or increase in individuals with neuromuscular disorders, necessitating careful monitoring. Patients with myasthenia gravis are notably sensitive to these agents.</p>
          </list-item>
          <list-item>
            <p>Burn Injuries: An increased presence of nAChRs due to burn injuries leads to resistance to nondepolarizing NMBAs, shortening their duration of action.</p>
          </list-item>
          <list-item>
            <p>Age-Related Considerations: In older adults, the effects of steroidal nondepolarizing NMBAs can be prolonged due to various physiological changes.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Obesity: Studies on the effects of obesity on nondepolarizing NMBAs have been inconclusive, but it's generally recommended to calculate doses based on ideal body weight plus an additional 10%.</p>
          </list-item>
          <list-item>
            <p>Liver and Kidney Diseases: Benzylisoquinolinium NMBAs are a good choice because their elimination isn't reliant on these organs.</p>
          </list-item>
          <list-item>
            <p>Physiological Factors: Hypothermia can prolong the effects of nondepolarizing NMBAs. Hypermagnesemia potentiates the effects of these drugs, while hypercalcemia can diminish their efficacy. Acidosis or alkalosis can lengthen or shorten the effects of nondepolarizing NMBAs, respectively.<xref ref-type="bibr" rid="article-25810.r8">[8]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Drug interactions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Antimicrobials like aminoglycosides, tetracyclines, polymyxins, and clindamycin can potentiate neuromuscular blockade.<xref ref-type="bibr" rid="article-25810.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Inhaled anesthetics can potentiate neuromuscular blockade when used with nondepolarizing NMBAs.<xref ref-type="bibr" rid="article-25810.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Anti-seizure medications can make patients resistant to nondepolarizing NMBAs.</p>
          </list-item>
          <list-item>
            <p>Lithium can potentiate neuromuscular blockade in both depolarizing and nondepolarizing NMBAs.<xref ref-type="bibr" rid="article-25810.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Local anesthetics can potentiate neuromuscular blockade in both depolarizing and nondepolarizing NMBAs.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25810.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Neuromuscular blockers are commonly administered during anesthesia to assist with endotracheal intubation and improve surgical conditions. It is essential to understand when each class of NMBAs should be used and when they should be avoided. The depth of paralysis should be closely monitored via TOF for the duration of the procedure, and the physician should always be aware of potential medications, physiologic derangements, or genetic disorders that could lead to potentiation of neuromuscular blockade, leading to postoperative complications.</p>
        <p>Of particular interest to the anesthesia care team, pseudocholinesterase (butyrylcholinesterase) deficiency may prolong the neuromuscular blockade of succinylcholine or mivacurium.&#x000a0;Pseudocholinesterase metabolizes these drugs in the plasma to inactive forms. Prolongation of neuromuscular blockade due to pseudocholinesterase deficiency&#x000a0;is most pronounced in patients who are homozygous for a defective pseudocholinesterase enzyme. Other factors can affect the levels of pseudocholinesterase in the plasma, like pregnancy, advanced age, severe liver disease, burn injuries, and drug interactions.<xref ref-type="bibr" rid="article-25810.r3">[3]</xref></p>
      </sec>
      <sec id="article-25810.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The healthcare team, ie, physicians, certified registered nurse anesthetists (CRNA), and pharmacists, must work together to ensure that patients undergoing neuromuscular blockade are carefully monitored for adverse events. A complete medication list for the patient is necessary before administering an NMBA to prevent significant drug interactions, and a pharmacist should perform medication reconciliation to avoid drug interactions and medication errors and report to the anesthesiologist in case of discrepancy. An interprofessional team approach between pharmacists and the anesthesia care team improves the safety of perioperative care.<xref ref-type="bibr" rid="article-25810.r12">[12]</xref></p>
      </sec>
      <sec id="article-25810.s5" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>The following are the recommendations from the 2023 American Society of Anesthesiologists (ASA) practice guidelines for neuromuscular blockade.<xref ref-type="bibr" rid="article-25810.r6">[6]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Due to its low sensitivity, ASA recommends not relying solely on clinical assessment for neuromuscular blockade.</p>
          </list-item>
          <list-item>
            <p>Select quantitative monitoring over qualitative assessment to control residual neuromuscular blockade.</p>
          </list-item>
          <list-item>
            <p>Clinicians should confirm a&#x000a0;TOF ratio &#x02265; 0.9 before extubation when utilizing quantitative monitoring.</p>
          </list-item>
          <list-item>
            <p>Utilize the adductor pollicis muscle for neuromuscular monitoring.</p>
          </list-item>
          <list-item>
            <p>Avoid using ocular muscles for neuromuscular monitoring.</p>
          </list-item>
          <list-item>
            <p>Clinicians can consider neostigmine as a suitable alternative to sugammadex at the minimal depth of neuromuscular blockade.</p>
          </list-item>
          <list-item>
            <p>Consider neostigmine antagonism at minimal neuromuscular blockade depth when using atracurium or cisatracurium to avoid residual blockade. ASA suggests that in the absence of quantitative monitoring, it is advisable to allow a minimum of 10 minutes to elapse after neostigmine-induced reversal to reasonably ensure adequate recovery of the block before proceeding with extubation.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25810.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25810&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25810">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25810/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25810">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25810.s7">
        <title>References</title>
        <ref id="article-25810.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gulenay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mathai</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <chapter-title>Depolarizing Neuromuscular Blocking Drugs</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">30422589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Furqan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparing The Functional Outcome Of Different Dose Regimes Of Succinylcholine When Used For Rapid Induction And Intubation.</article-title>
            <source>J Ayub Med Coll Abbottabad</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>401</fpage>
            <page-range>401-404</page-range>
            <pub-id pub-id-type="pmid">30465374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wildgaard</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.</article-title>
            <source>Anaesthesia</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>518</fpage>
            <page-range>518-528</page-range>
            <pub-id pub-id-type="pmid">30600548</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thilen</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Cain</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Treggiari</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bhananker</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.</article-title>
            <source>Br J Anaesth</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>367</fpage>
            <page-range>367-377</page-range>
            <pub-id pub-id-type="pmid">30032875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <article-title>Evaluation of Residual Neuromuscular Block Using Train-of-Four and Double Burst Stimulation at the Index Finger: Retraction Notice.</article-title>
            <source>Anesth Analg</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>e16</fpage>
            <pub-id pub-id-type="pmid">30550474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thilen</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Weigel</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Dutton</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Lien</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Szokol</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Eriksson</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Yaster</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Agarkar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marbella</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Blanck</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Domino</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade.</article-title>
            <source>Anesthesiology</source>
            <year>2023</year>
            <month>Jan</month>
            <day>01</day>
            <volume>138</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-41</page-range>
            <pub-id pub-id-type="pmid">36520073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r7">
          <label>7</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hager</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Succinylcholine Chloride</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>2</month>
            <day>20</day>
            <pub-id pub-id-type="pmid">29763160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Clar</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Nondepolarizing Neuromuscular Blockers</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30521249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Bae</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade.</article-title>
            <source>Korean J Anesthesiol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-51</page-range>
            <pub-id pub-id-type="pmid">23459675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Motamed</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time.</article-title>
            <source>Can J Anaesth</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>49</volume>
            <issue>9</issue>
            <fpage>907</fpage>
            <page-range>907-12</page-range>
            <pub-id pub-id-type="pmid">12419714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karalliedde</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Drug interactions with neuromuscular blockers.</article-title>
            <source>Drug Saf</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>261</fpage>
            <page-range>261-73</page-range>
            <pub-id pub-id-type="pmid">8905251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25810.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renaudin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leguelinel-Blache</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Choukroun</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lefauconnier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boisson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kinowski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cuvillon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Impact of a preoperative pharmaceutical consultation in scheduled orthopedic surgery on admission: a prospective observational study.</article-title>
            <source>BMC Health Serv Res</source>
            <year>2020</year>
            <month>Aug</month>
            <day>13</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>747</fpage>
            <pub-id pub-id-type="pmid">32791965</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
